TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project

The Screen4Care TREAT-panel provides a curated, scientifically robust gene set for gNBS, focusing on treatable RDs with early onset and clinical actionability. The panel will be tested in a European pilot project involving approximately 20,000 newborns, contributing to the growing body of evidence for the implementation of next-generation sequencing (NGS) in newborn screening programs.

Authors

Institutions

Publication Details

Journal
Orphanet Journal of Rare Diseases
Published
2025-05-15
DOI
https://doi.org/10.1186/s13023-025-03692-6
Citations
2
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
3.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project

Stefaan Sansen, Moshe Einhorn, Christina Saier, Emanuele Agolini et al.
2 citations
Orphanet Journal of Rare Diseases
Genomics and Rare Diseases
3.63
article

TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project

Stefaan Sansen, Moshe Einhorn, Christina Saier, Emanuele Agolini, Rita Selvatici, Antonio Novelli, Janbernd Kirschner, F. Fortunato, Joanne Berghout, Alessandra Ferlini, Nicolas Garnier, Maria Martínez-Fresno, Sergi Beltrán, Yaron Einhorn, Gulcin Gumus, Enrico Bertini, Silvia Montanari, Kathrin Freyler
article en
2 citations

Abstract

The Screen4Care TREAT-panel provides a curated, scientifically robust gene set for gNBS, focusing on treatable RDs with early onset and clinical actionability. The panel will be tested in a European pilot project involving approximately 20,000 newborns, contributing to the growing body of evidence for the implementation of next-generation sequencing (NGS) in newborn screening programs.

Orphanet Journal of Rare DiseasesVol. 20(1)
European Organisation for Rare Diseases (FR), Illumina (United States) (US), Pfizer (United States) (US), University of Ferrara (IT), University Medical Center Freiburg (DE), Consorzio Futuro in Ricerca (IT), Sanofi (Belgium) (BE), Bambino Gesù Children's Hospital (IT), Servier (France) (FR), Centro Nacional de Análisis Genómico (ES), University Hospital in Halle (DE)
Reduced inequalities
Openalex Percentile: Top 8%
Genomics and Rare Diseases
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.